Research presented at JADPRO Live 2024 illuminated the diagnostic experiences of patients with colorectal cancer. Researchers presented the results of the intervention program at JADPRO Live, the Annual APSHO Meeting. The FDA also approved the VENTANA CLDN18 RxDx Assay as a companion diagnostic device. Kohei Shitara, MD, unpacks the SPOTLIGHT and GLOW data behind the approval. Oncology nurses can play a key role in improving outcomes and quality of life for patients with metastatic pancreatic cancer. Learn how oncology nurses can help patients navigate the evolving landscape of screening options. Learn about the TRANSMET trial and several important nursing considerations. The CheckMate 9DW clinical trial results support the combination as a potential new first-line standard of care. Martha Raymond, MA, highlights the patient advocacy networking and learning opportunities available at the conference. A new study highlights the effectiveness of a nurse navigation program for patients undergoing treatment for these cancers. It’s critical to consider the patient’s life, experiences, and preferences in a holistic sense. Learn how a team developed tip sheets for GI cancer education. Researchers aimed to identify the best timing for telenursing follow-up after chemotherapy. A team aimed to address the downward trend in colorectal cancer screening compliance in middle-aged adults. Health-related quality of life is at a “high risk for deterioration" in survivors of colorectal cancer. Fatemeh Youssefi, PhD, RN, OCN, discusses how oncology nurses can promote health literacy regarding GI cancers. Learn how oncology nurses can provide support and resources when body image concerns arise in patients with GI cancer. Learn how a team implemented a simple tool to screen for malnutrition in patients with GI cancer. Paula Aguilera, RN, BSN, OCN, speaks about her ONS Congress poster presentation on the project. Chronic pain “has emerged as one of the most prevalent issues” in survivors of GI cancer.